![1]()
News
Empagliflozin favorably reshaped left ventricles in HFrEF patients
November 15, 2020
Results from two separate randomized studies showed empagliflozin treatment of patients with HFrEF produced significant heart remodeling.
![1]()
News
Intravenous iron reduces HF readmissions: AFFIRM-AHF
November 14, 2020
The results are likely to change heart failure guidelines, which currently give a lukewarm recommendation for intravenous iron in the US, experts say.
![1]()
News
GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit
November 13, 2020
Omecamtiv mecarbil safely met its primary efficacy endpoint in patients with heart failure with reduced ejection fraction in GALACTIC-HF, but with a modest effect.
News
Escalate HIV adherence strategies amid COVID-19
November 13, 2020
Virtual care is not meeting the needs of people with HIV who struggled with viral suppression even before the COVID-19 pandemic.
News
Situation ‘dire’ as COVID spike in West, Midwest worsens, experts say
November 13, 2020
“I think the situation in 2 to 4 weeks is going to be grim,” said Dr. Andrew Pavia.
News
Nearly one in five develop mental illness following COVID-19
November 13, 2020
The study also showed that having a psychiatric disorder independently increases the risk of getting COVID-19.
News
New reports guide return to play in athletes with COVID-19
November 13, 2020
Researchers found a high prevalence of pericardial involvement in college-student athletes who have recovered from COVID-19.
![1]()
News
AMA creates COVID-19 CPT codes for Pfizer, Moderna vaccines
November 13, 2020
AMA plans to introduce more vaccine-specific CPT codes as more vaccine candidates approach FDA review.
![1]()
News
Monthly needlestick rates suggest a steep learning curve
November 12, 2020
Nonsurgical specialists should receive more training in injury prevention.
News
Nearly 10% of hospitalized patients with COVID-19 later readmitted
November 12, 2020
The short interval before readmission suggests that patients are probably not suffering a relapse, but more likely experienced some adverse event, such as difficulty breathing.
